Health Care & Life Sciences » Biotechnology | Xeno Transplants Corp.

Xeno Transplants Corp. | Income Statement

Fiscal year is July-June. All values USD Thousands.
2005
2006
2007
Cost of Goods Sold (COGS) incl. D&A
-
0.40
-
Gross Income
-
0.40
-
SG&A Expense
32.60
46.30
256.40
Unusual Expense
-
-
0.70
Non Operating Income/Expense
-
-
0.70
Interest Expense
0.20
-
-
Pretax Income
32.70
46.70
256.40
Consolidated Net Income
32.70
46.70
256.40
Net Income
32.70
46.70
256.40
Net Income After Extraordinaries
32.70
46.70
256.40
Net Income Available to Common
32.70
46.70
256.40
EPS (Basic)
0.00
0.00
0.01
Basic Shares Outstanding
16,293.70
22,920.80
33,182.00
EPS (Diluted)
0.00
0.00
0.01
Diluted Shares Outstanding
16,293.70
22,920.80
33,182.00
EBITDA
32.60
46.30
256.40

About Xeno Transplants

View Profile
Address
1066 West Hastings Street
Vancouver British Columbia V6E 3X2
Canada
Employees -
Website -
Updated 07/08/2019
Develops therapeutic applications .